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Table. Postoperative care in elective EVAR patients:
Mean number of hours treatment was utilized or time
initiated
Indicator (%) Mean Hours Postop
Oxygen 98.5 19
Telemetry 100 12
Arterial catheter 27.3 6
Continuous IV 86.4 12.5
IV ﬂuid bolus 16.7 3.5 (initiated)
IV medication 52.4
Indwelling urinary catheter 67.2 19
Straight catheterization 4.5 14 (initiated)
<3 Laboratory tests 76.2
Diabetic management 37.3
JOURNAL OF VASCULAR SURGERY
Volume 59, Number 6S Abstracts 65Sassigned a set of academic effort values and a series of
modulators to describe the strength and weakness of an
activity. Only ongoing productive activities were
measured, and no allowances were made for tenure or
previous achievements.
Results: All activities had effort apportioned to
them. Publications were modulated by type, author po-
sition, and journal impact factor. Presentations were
modulated by level of participation, meeting type and
continuing medical education credit. Grants were
weighted by funding source, annual income, and inves-
tigator classiﬁcation, whereas clinical trials were assesses
by status of recruitment and ﬁnancial reimbursement.
Teaching was based on deﬁned activities, contributions
to the curriculum, and learner scores. When faculty
members were assessed and their budgeted time alloca-
tions compared, all the faculty exceeded their effort re-
quirements. Examples of the system applications to a
clinician, clinician administrator, clinician educator and
clinician researcher will be shown.
Conclusions: Adoption of a universal system of
measuring academic performance is necessary to facilitate fac-
ulty focus and development and allow for a rational budget-
ing of academic time and effort. Production and validation of
the aRVU will allow for constructive and appropriate recog-
nition of activity and contributions to the academic mission.
Author Disclosures: J. Bismuth: Nothing to disclose;M.
G. Davies: Nothing to disclose; H. F. El-sayed: Nothing
to disclose; U. Fischer: Nothing to disclose; A. B.
Lumsden: Nothing to disclose; E. K. Peden: Nothing to
disclose; A. Sigdel: Nothing to disclose; M. Unruh:
Nothing to disclose; H. K. Younes: Nothing to disclose.PS130.
Clinical Feasibility and Financial Impact of Same-Day
Discharge in Patients Undergoing Endovascular
Aortic Repair (EVAR) for Elective Infra-Abdominal
Aortic Aneurysm (AAA)
Vincent Moscato, Monica O’Brien-Irr, Maciej Dryjski,
Linda Harris. Department of Surgery, Buffalo General
Medical Center, Buffalo, NY
Objectives: To evaluate the potential feasibility and
ﬁnancial impact of same-day discharge after elective endo-
vascular aneurysm repair (EVAR) for abdominal aortic
aneurysm (AAA).
Methods: All elective EVAR patients from January
2012 to June 2013 were identiﬁed. Demographics,
comorbidities, complications, nursing care, ﬁnancial data,
and length of stay (LOS) were analyzed (SPSS 21).
Results: The Table presents care received in 67 elec-
tive EVAR (70% percutaneous EVAR/61% of AAA). Intra-
operative and postoperative complications were type I
endoleak, 1.5%; thrombosis, 3%; blood loss requiring trans-
fusion, 4.5%; urinary retention, 4.5%; myocardial infarc-
tion, 3%; and hemodynamic/rhythm alterations, 37%
(evident in 24 [88%] <6 hours; 13% required therapy).
Monitoring only was needed in 28 (42%), intensive care
unit in 13.4%. Postoperative day 1 discharge occurred in
73%; 9% <30-day readmission. Total hospital costs:
$29,479: operating room, 80.3%; anesthesia, 2.2%; pread-
mission, 1%; postanesthesia unit, 3.1%; intensive care unit,1.9%; ﬂoor, 4.7%; laboratory/diagnostic tests, 1.2%; phar-
macy, 1.4%; and other, 4.2%. Total cost was similar for
those discharged <24 or >25 hours postoperatively (P ¼
.88) and for monitoring only vs others ($28,146 vs
$30,545; P ¼ .12). Costs for pharmacy ($351 vs $509: P
¼ .05) and laboratory ($86 vs $354: P ¼ .01) and diag-
nostic testing ($3.96 vs $254: P ¼ .02) were lower for un-
complicated cases.
Conclusions: Same-day discharge is clinically feasible
in >40% of elective EVAR, but requires coordination for
adequate postoperative monitoring. Signiﬁcant savings is
unlikely because most cost is operating room- and de-
vice-related, and further reduction of costs in uncompli-
cated cases is unlikely.Author Disclosures: M. Dryjski: Nothing to disclose; L.
Harris: Nothing to disclose; V. Moscato: Nothing to
disclose; M. O’Brien-Irr: Nothing to disclose.PS132.
Mitigating Mortality in Abdominal Aortic Aneurysmal
Disease Through the Use of a Risk Register:
Indications for EVAR vs Open Repair
Sapan S. Desai2, Anahita Dua1, SreyRam Kuy1, Gilbert R.
Upchurch3. 1Medical College of Wisconsin, Milwaukee,
Wisc; 2Department of Surgery, Duke University,
Houston, Tex; 3University of Virginia, Charlottesville, Va
Objectives: This study aimed to determine risk factors
associated with perioperative mortality in patients undergo-
ing abdominal aortic aneurysm (AAA) repair nationally and
use these risk factors to create a scoring system and risk reg-
ister to determine mortality rate based on risk scores.
Methods: A retrospective analysis was completed us-
ing the National Inpatient Sample (NIS) from 2000 to
2010. A discriminant analysis was used to predict in-hospi-
tal mortality once predictor variables were identiﬁed using a
multivariate analysis. A risk register was created using
established rates of rupture for various AAA sizes and esti-
mating the average mortality for those patients. This risk
was then compared with the in-hospital mortality risk using
our discriminant analysis to make recommendations on
minimizing overall mortality as a function of aneurysm
size and predictors of mortality.
Results: In the past decade in the United States,
101,978 patients underwent an AAA repair, of which
95,098 survived and 6,780 (7%) died. The following
Fig.
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assigned point values based on impact on survival: rupture
(10 points), anticoagulation usage (4 points), renal failure
(1 point), and female gender (1 point). Patients with the
lowest risk of mortality were those with a score ranging
from e4 to 1 (1.4% risk of mortality), followed by those
with a range of 2 to 6 (13.3% mortality risk), 7 to 12
(33% mortality risk), and ﬁnally 13 to 16 (45.5%) risk of
death. A risk register was created with these data.
Conclusions: This study demonstrates that not all pa-
tients with AAA between 5 and 5.5 cm are candidates for
surgery. Higher-risk patients may beneﬁt from endovascu-
lar aneurysm repair (EVAR), and those patients with
smaller aneurysm sizes and few risk factors may beneﬁt
from observation. Women, patients with renal failure, and
anticoagulated patients all have a greater risk of in-hospital
mortality. Patients who undergo EVAR have signiﬁcantly
lower in-hospital mortality, especially those patients who
have a ruptured AAA.
Author Disclosures: S. S. Desai: Nothing to disclose; A.
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Does Increased Cost in the Treatment of Superﬁcial
Femoral Artery Disease Lead to Better Outcomes?
Karen L. Walker, Jesse A. Columbo, Eva M. Rzucidlo,
Samuel T. Simone, Philip P. Goodney, Richard J. Powell.
Vascular Surgery, Dartmouth Hitchcock, Lebanon, NH
Objectives: Patients considered for endovascular treat-
ment of superﬁcial femoral artery (SFA) disease present
with a wide array of lesion complexity and treatment op-
tions. This study aims to examine the cost drivers of SFA
stent treatment and their impact on outcome.
Methods: We retrospectively collected clinical and
ﬁnancial data on patients undergoing SFA stenting to eval-
uate the relationship between direct procedural cost and 1-
year patency. Adjuncts to SFA stenting were deﬁned as
stent grafts, atherectomy, re-entry, and embolic protection
devices.
Results: We studied 95 patients who underwent SFA
stenting from January 2010 to February 2012. Patients
were a mean age of 71 years, 62% were male, 41% were
diabetic, 46% had critical limb ischemia (CLI), and 24%
had a TASC C or D lesion. Primary patency at 1 year
was better in patients with claudication than those with
CLI (91% vs 74%, P ¼ .06). Whereas the rate of adjunct
use was similar in patients with claudication and CLI
(12%), more adjuncts were used in patients with TASC
C and D lesions (22% C and D, 8% A and B, P ¼ .09).
Mean direct costs for SFA stenting without adjunct use
was $2838 (95% conﬁdence interval, $2586-$3089),
whereas adjunct use increased mean costs to $7318
(95% conﬁdence interval, $4817-$9820; P < .01). Multi-
variate regression showed that TASC C/D classiﬁcation
and adjunct use were associated with the highest tertile
of costs, OR 13.5 and 36.8 respectively (P < .01). There
was no association between cost and primary patency
(Fig).
Conclusions: Adjunct devices are often necessary to
achieve technical success for treatment of TASC C and DSFA lesions. Their use is associated with increased cost,
yet has limited impact on midterm patency.
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Results of the Retrocarotid Dissection Technique in
the Treatment of Carotid Body Tumors
Carlos A. Hinojosa1, Laura J. Ortiz-López1, Vicente
Orozco-Sevilla2, Ana E. Nuñez-Salgado1. 1Section of
Vascular Surgery and Endovascular Therapy, National
Institute of Medical Sciences and Nutrition “Salvador
Zubirán,” Mexico City, Mexico; 2Mount Sinai School of
Medicine, Department of Cardiothoracic Surgery, New
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Objectives: To determine if the retrocarotid dissection
technique has advantages over the standard caudal-cranial
approach in regards of bleeding, surgical time, vascular or
nervous injury, and hospital stay in patients with carotid
body tumors (CBT).
Methods: A prospective cohort of patients who under-
went surgical treatment with retrocarotid dissection tech-
nique (RC) at our institution between July 2007 and
January 2013 was reviewed. This cohort was compared
with a historical group of patients treated with standard
approach (SA; caudal-cranial dissection) between 1995 and
2007. Intraoperative parameters and operative outcomes
were compared using the Fisher exact test for categoric vari-
ables, and Mann-Whitney U test for continuous variables. A
P < .05 was considered as statistically signiﬁcant.
Results: A total of 68 resections (41 SA, 27 RC) in 68
patients (62 female and 8 male; mean age, 54.3 years) were
performed. Comparative analysis identiﬁed mean blood
loss of 476 mL (standard deviation [SD] 378 mL) in the
RC group and 694.39 mL (SD, 682 mL) for the SA cohort
(P <. 31). The mean surgical time was 172 minutes (SD,
60 minutes) for the RC group and 260 minutes (SD,
97.7 minutes) for the SA group (P <. 001). The hospital
stay was signiﬁcantly shorter for the RC group with an
